SEC Form 4 · accession 0001104659-17-004567
AGILE THERAPEUTICS INC · AGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Renee Selman
Officer — Chief Commercial Officer
Period of report
Jan 25, 2017
Accepted (ET)
Jan 27, 2017 · 4:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001261249
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $2.26 | Jan 25, 2017 | A | 125,000 | A | — | Jan 24, 2027 | Common Stock | 125,000 | 125,000 | D |
| Restricted Stock UnitsF1,F3 | — | Jan 25, 2017 | A | 35,000 | A | — | — | Common Stock | 35,000 | 35,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of common stock.
- F2This option was granted on January 25, 2017. 25% of the shares subject to the stock option vest on January 25, 2018, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on January 25, 2021.
- F3The restricted stock units were granted on January 25, 2017 and vest as follows: 17,500 units will vest and be delivered on January 25, 2018, and 17,500 units will vest and be delivered on January 25, 2019.